340 related articles for article (PubMed ID: 11493936)
1. Reporting of fatal adverse drug reactions.
Liu BA; Knowles SR; Mittmann N; Einarson T; Shear NH
Can J Clin Pharmacol; 2001; 8(2):84-8. PubMed ID: 11493936
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
3. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Ladewski LA; Belknap SM; Nebeker JR; Sartor O; Lyons EA; Kuzel TC; Tallman MS; Raisch DW; Auerbach AR; Schumock GT; Kwaan HC; Bennett CL
J Clin Oncol; 2003 Oct; 21(20):3859-66. PubMed ID: 14551305
[TBL] [Abstract][Full Text] [Related]
4. Paediatric adverse drug reaction reporting: understanding and future directions.
Carleton BC; Smith MA; Gelin MN; Heathcote SC
Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
6. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
Kimland E; Rane A; Ufer M; Panagiotidis G
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
[TBL] [Abstract][Full Text] [Related]
7. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
Wester K; Jönsson A; Spigset O; Hägg S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
[TBL] [Abstract][Full Text] [Related]
8. Under-reporting of serious adverse drug reactions in Sweden.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
[TBL] [Abstract][Full Text] [Related]
10. Nurses are increasingly involved in pharmacovigilance in Sweden.
Ulfvarson J; Mejyr S; Bergman U
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
[TBL] [Abstract][Full Text] [Related]
11. Use of a database computer program to identify trends in reporting of adverse drug reactions.
Johnston PE; Morrow JD; Branch RA
Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
[TBL] [Abstract][Full Text] [Related]
12. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
Koh Y; Yap CW; Li SC
Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
Tiaden JD; Wenzel E; Berthold HK; Müller-Oerlinghausen B
Semin Thromb Hemost; 2005; 31(4):371-80. PubMed ID: 16149013
[TBL] [Abstract][Full Text] [Related]
14. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
Ramesh M; Pandit J; Parthasarathi G
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
[TBL] [Abstract][Full Text] [Related]
16. The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients.
Calderón-Ospina C; Bustamante-Rojas C
Int J Pharm Pract; 2010 Aug; 18(4):230-5. PubMed ID: 20636675
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
18. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
Layton D; Key C; Shakir SA
Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
[TBL] [Abstract][Full Text] [Related]
20. Incidence of adverse drug reactions in adult medical inpatients.
Bowman L; Carlstedt BC; Black CD
Can J Hosp Pharm; 1994 Oct; 47(5):209-16. PubMed ID: 10172139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
